These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 17487761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP, Mikhailidis DP, Moross T, Benson K, Gor M.
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
    Jaussi A, Noll G, Meier B, Darioli R.
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of statins in the treatment of diabetic dyslipidemia.
    Berriche O, Amrouche C, Jamoussi H, Blouza S.
    Tunis Med; 2010 Feb; 88(2):80-4. PubMed ID: 20415163
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
    Pérez A, González Blanco C, Hernández-Presa MÁ, Chaves J.
    Endocrinol Nutr; 2011 Feb; 58(6):283-90. PubMed ID: 21641286
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T, Laloi-Michelin M, Virally M, Peynet J, Giraudeaux V, Kévorkian JP, Guillausseau PJ.
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [Abstract] [Full Text] [Related]

  • 15. [Lipid-lowering therapy in patients with type-2 diabetes mellitus].
    Pados G, Audikovszky M.
    Orv Hetil; 2003 Mar 23; 144(12):557-61. PubMed ID: 12723526
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA, Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.
    Am J Cardiol; 2009 Sep 15; 104(6):798-804. PubMed ID: 19733714
    [Abstract] [Full Text] [Related]

  • 17. [Treatment for dyslipidemias in patients with arterial hypertension].
    Chazova IE, Kukharchuk VV, Ratova LG, Kaminnaia VI.
    Ter Arkh; 2007 Sep 15; 79(4):53-7. PubMed ID: 17564020
    [Abstract] [Full Text] [Related]

  • 18. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Sep 15; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ, Merikle E, Jones J.
    Clin Ther; 2007 Apr 15; 29(4):742-50. PubMed ID: 17617298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.